Citations 1

Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab

Geburtshilfe und Frauenheilkunde | January 2, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0038-1675442